Search Hotels in Livermore

With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income.

Looking For Passive Income? This Dividend Portfolio Will Pay You Monthly

October 18, 2023

Via Benzinga

Dividend Income Update September 2023

October 18, 2023

Via Talk Markets

Is the Ozempic-Driven DexCom Selloff Overdone?

October 18, 2023

Has glucose monitor maker DexCom corrected too much on fears of lost sales due to weight loss and diabetes drugs made by Novo Nordisk and Eli Lilly?

The Consumer Staples Select Sector SPDR ETF (XLP) is approaching a crucial support level, potentially signaling a rebound opportunity for investors

Consumer Staples Find Support, Signal Opportunity

October 18, 2023

The global leader in non-alcoholic beverages is on a good path to decades more of success.

Topics ETFs

Check Out What Whales Are Doing With PEP

October 17, 2023

Via Benzinga

Coca-Cola Stock: Buy, Sell, or Hold?

October 13, 2023

You need new growth stocks to fuel the next market rally. These two stocks have roughly doubled over the past year.

(PEP) - Analyzing PepsiCo's Short Interest

October 12, 2023

Via Benzinga

These 2 High-Growth Stocks Could Power the Bull Market's Next Record Run

October 17, 2023

Investors should brush off Ozempic selloff fears and dive into tasty food and beverage stocks that have been oversold in 2023.

Food and Beverage Stocks Look Appetizing After Ozempic Selloff

October 16, 2023

If Mondelez beats consensus for Q3 and can offer reassurance about the potential impact of Ozempic, investors’ appetite for chewed up snack makers may improve.

Snack Maker Mondelez Int'l Is Down but Not Out

October 16, 2023

Founded in 1889, McCormick is now a global leader in flavor by manufacturing, marketing, and distributing spices, seasoning mixes, condiments, and other flavorful products to food retailers. The...

McCormick: A Leading Spice And Seasoning Maker With A Solid Dividend

October 14, 2023

Via Talk Markets

Looking At PepsiCo's Recent Unusual Options Activity

October 11, 2023

Via Benzinga

Pepsi CEO Addresses Weight Loss Drug Concerns, Sees No Impact On Business

October 11, 2023

Via Benzinga

Retire Early with These 7 Millionaire-Maker Growth Stocks

October 14, 2023

if you want to enjoy passive income and an early retirement, invest in these must-have growth stocks for your retirement portfolio.

Are Ozempic and Similar Treatments Impacting Food and Beverage Stocks? Here's What Pepsi's CFO Said About It

Topics Retirement

Exposures Pension

October 14, 2023

PepsiCo's Q3 earnings may have shed some light on the long-standing speculation about Ozempic's impact on consumer staples.

Stocks remained under pressure this week as investors wrestled with higher inflation being fueled by surging oil prices and what that means for their portfolio

MarketBeat Week in Review – 10/9 - 10/13

October 14, 2023

These dividend kings earn consistent income from steadily growing payments. Buy these stocks that have risen for 50 years or more.

Topics Economy

Exposures Economy Interest Rates

7 Dividend Kings to Buy for Royal Returns

October 13, 2023

Is the economy falling off a cliff, headed for a slow landing, or just getting ready to take off is a question that every investor is looking for an answer to these days.

Stable But Split

October 13, 2023

Via Talk Markets

Topics Economy

Exposures Economy

3 Stocks You Can Keep Forever

October 13, 2023

Here are three businesses with strong competitive moats and increasing dividend payments that you can park safely in your portfolio forever.

The buy-and-hold investment strategy is on full display with these Warren Buffett stocks that he has owned for over a decade or more.

3 Stocks Warren Buffett Refuses to Let Go Of

October 12, 2023

Novo Nordisk's Ozempic, a weight loss drug, is making waves in the food industry, raising concerns about its effect on sales of calorie-laden products.

Will Higher Ozempic Use Mean Slimmed-Down Food Sales?

October 12, 2023

Investors should take advantage of the recent market turmoil to buy these rock-solid blue-chip stocks at distressed prices.

Buy Low, Sell High: 7 Blue-Chip Stocks to Snatch Up

October 11, 2023

PepsiCo Shines Amid Volatility: Analyst Consensus Points To Solid Earnings But Volume Growth Concerns Linger

October 11, 2023

Beverage giant PepsiCo Inc (NASDAQ: PEP) reported third-quarter FY23 results yesterday, with sales growth of 6.7% year-on-year to $23.45 billion, beating the analyst consensus of $23.43 billion.

Via Benzinga

Recession Resistant: 3 Defensive Sector Stocks to Weather Any Storm

October 11, 2023

These three defensive stocks continue to deliver stock price growth and rising dividends regardless of conditions in the overall economy.

Find out who the winners and losers are.

Topics Economy

Exposures Economy

Ozempic Is Moving a Bunch of Stocks Wednesday Morning

October 11, 2023

PepsiCo Inc (NASDAQ: PEP) on Tuesday reported better-than-expected earnings for its third quarter.

How To Earn $500 A Month From PepsiCo Stock Following Upbeat Quarterly Earnings

October 11, 2023

Via Benzinga

Investor Worries Ease Amid Falling Treasury Yields But Stay In 'Fear' Zone

October 11, 2023

The CNN Money Fear and Greed index showed further easing in the fear level but remained in the "Fear" zone on Tuesday. U.S. stocks settled higher on Tuesday, as investors assessed the ongoing conflict...

Via Benzinga

7 Beaten-Down Blue Chips Ready to Rebound in October

October 10, 2023

Blue-chip stocks are on sale after last month's market mayhem, representing perfect entry points for buy-and-hold investors